What is the recommended dose for the influenza (flu) virus vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Influenza Vaccine Dosing Recommendations

The recommended dose of influenza vaccine depends on age and vaccination history: children 6-35 months receive either 0.25 mL or 0.5 mL depending on the specific vaccine product, children ≥36 months and adults receive 0.5 mL, and adults ≥65 years receive either 0.5 mL (standard dose) or 0.7 mL (high-dose formulation). 1

Dose Volume by Age Group

Children 6-35 Months

The dose volume varies by vaccine brand for this age group 1:

  • Afluria: 0.25 mL per dose (7.5 μg HA per virus) 1
  • Fluarix: 0.5 mL per dose (15 μg HA per virus) 1
  • Flucelvax: 0.5 mL per dose (15 μg HA per virus) 1
  • FluLaval: 0.5 mL per dose (15 μg HA per virus) 1
  • Fluzone: Either 0.25 mL or 0.5 mL per dose (both acceptable) 1

Important caveat: The 0.25 mL prefilled syringes are no longer widely available for most products, so the appropriate volume must be drawn from multidose vials when a 0.25 mL dose is indicated 1.

Children ≥36 Months Through Adults <65 Years

  • Standard dose: 0.5 mL per dose (15 μg HA per virus) for all inactivated influenza vaccines 1
  • Live attenuated vaccine (LAIV): 0.2 mL intranasally (0.1 mL per nostril) for ages 2-49 years 1
  • Recombinant vaccine (RIV): 0.5 mL per dose (45 μg HA per virus) for ages ≥18 years 1

Adults ≥65 Years

  • Standard dose: 0.5 mL per dose 1
  • High-dose vaccine (Fluzone High-Dose): 0.7 mL per dose (60 μg HA per virus, 180 μg total) 1
  • Adjuvanted vaccine (Fluad): 0.5 mL per dose (15 μg HA per virus with MF59 adjuvant) 1

Number of Doses Required

Children 6 Months Through 8 Years

The number of doses depends on prior vaccination history 1:

  • One dose needed: Children who have previously received ≥2 total doses of influenza vaccine (trivalent or quadrivalent) ≥4 weeks apart before July 1 of the current season 1

    • The 2 previous doses do not need to have been received in the same season or consecutive seasons 1
  • Two doses needed: Children who have not previously received ≥2 doses ≥4 weeks apart, or whose vaccination history is unknown 1

    • Doses must be administered ≥4 weeks apart 1
    • Both doses should be given even if the child turns 9 years between dose 1 and dose 2 1
    • First dose should be given as soon as vaccine is available to allow the second dose to be received by end of October 1

Evidence supporting two-dose schedule: A 2025 meta-analysis found that receiving 2 doses of inactivated influenza vaccine was associated with a 28 percentage point increase in vaccine effectiveness for children <3 years compared to one dose, though this benefit was not statistically significant when extended to children <9 years 2.

Children ≥9 Years and Adults

  • One dose per season regardless of vaccination history 1

Dosing Error Correction

If an incorrect dose volume is administered 1:

  • Underdosing in children ≥36 months: If a smaller dose (e.g., 0.25 mL) is inadvertently given, administer the remaining volume during the same visit, or if measuring is challenging, give a full 0.5 mL dose 1
  • If error discovered after patient leaves: Administer a full 0.5 mL dose as soon as the patient can return 1
  • Adult formulation given to child: Count as a valid single dose 1

Route of Administration

  • Inactivated vaccines: Intramuscular injection 1
    • Deltoid muscle preferred for adults and older children 1
    • Anterolateral thigh for infants and younger children 1
  • Live attenuated vaccine: Intranasal spray 1

Special Populations

Pregnant Persons

  • Any licensed, age-appropriate inactivated or recombinant vaccine at standard adult dose (0.5 mL) 1
  • LAIV should not be used during pregnancy 1
  • Can be administered at any time during pregnancy 1

Immunocompromised Persons

  • Standard dosing applies 1
  • LAIV should not be used 1
  • Solid organ transplant recipients aged 18-64 years on immunosuppressive medications may receive high-dose or adjuvanted vaccines without preference over standard-dose vaccines 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.